Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
APN Health is a private U.S. medical device company focused on electrophysiology mapping and imaging for cardiac ablation procedures. The company has developed Navik 3D, a software-driven, hardware-agnostic 3D cardiac imaging and mapping system that derives catheter location from 2D fluoroscopic images and displays anatomical, activation, and voltage maps in real time. APN positions the system as a lower-cost alternative to traditional 3D cardiac mapping platforms used in treating atrial fibrillation and other rhythm disorders. Navik 3D received FDA 510(k) clearance in February 2016, and APN has described ongoing product expansion including impedance mapping and integration work with pulse field ablation technologies. The company appears to operate as an active private medtech business headquartered in Waukesha, Wisconsin.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on APN Health.